Jānis Sarāns-Reneslācis
About
Jānis works in the firm’s litigation and dispute resolution, as well as competition law and intellectual property law practice groups. His areas of specialization are litigation, administrative proceedings in institutions, intellectual property rights disputes in courts, competition law infringement and damages disputes, as well as pharmaceutical and sports regulations.
Before joining COBALT, Jānis gained experience in other law firms in Latvia.
He is the recipient of the prestigious Fulbright scholarship to study law at the Straus Institute for Dispute Resolution at Pepperdine University Carusso School of Law, USA, Malibu.
Jānis is appointed a Member of the Disciplinary Anti-Doping Committee of the Anti-Doping Bureau of Latvia for the period of 2024-2028. He is appointed as the National Representative for the International Association of Young Lawyers (AIJA) in Latvia for a one-year term, starting September 2024.
- Intellectual Property – Rising star, IP STARS 2024
Languages
- Latvian, English
Membership & education
- Member of the Disciplinary Anti-Doping Committee, Anti-Doping Bureau of Latvia (2024-2028)
- National Representative for the International Association of Young Lawyers (AIJA) in Latvia (2024-2025)
- Latvian Bar Association (since 2017)
- Fulbright Association (since 2017)
- President, Latvian Moot Association (since 2018)
- LL.M. Dispute Resolution, Pepperdine University School of Law Straus Institute for Dispute Resolution, Malibu, USA (2018)
- Master of Law, University of Latvia, Riga, Latvia (2016)
- Bachelor of Law, University of Latvia, Riga, Latvia (2014)
Court upholds GEO PRO’s claim for copyright infringement and protection of geospatial information
Printify and Printful announce merger for accelerated growth in the global market
Families of young hockey players win court proceeding against a local Latvian hockey union
One of the world’s leading betting and gaming companies sells its Latvian business
COBALT advised Biogen on launching its operations in Latvia and Estonia
COBALT advised Pfizer’s Upjohn spin-off on merger with Mylan NV